IL139385A - Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis - Google Patents

Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis

Info

Publication number
IL139385A
IL139385A IL13938599A IL13938599A IL139385A IL 139385 A IL139385 A IL 139385A IL 13938599 A IL13938599 A IL 13938599A IL 13938599 A IL13938599 A IL 13938599A IL 139385 A IL139385 A IL 139385A
Authority
IL
Israel
Prior art keywords
diagnosis
metal complexes
labelled
glutamine
lysine analogues
Prior art date
Application number
IL13938599A
Other languages
English (en)
Other versions
IL139385A0 (en
Original Assignee
Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Plc filed Critical Amersham Plc
Publication of IL139385A0 publication Critical patent/IL139385A0/xx
Publication of IL139385A publication Critical patent/IL139385A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13938599A 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis IL139385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98303872 1998-05-15
PCT/GB1999/001550 WO1999060018A1 (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues

Publications (2)

Publication Number Publication Date
IL139385A0 IL139385A0 (en) 2001-11-25
IL139385A true IL139385A (en) 2005-09-25

Family

ID=8234827

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13938599A IL139385A (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis

Country Status (17)

Country Link
US (2) US7049289B1 (de)
EP (1) EP1077998B1 (de)
JP (2) JP4199420B2 (de)
KR (1) KR100660509B1 (de)
CN (2) CN1309661A (de)
AT (1) ATE384075T1 (de)
AU (1) AU762736B2 (de)
BR (1) BR9910468A (de)
CA (1) CA2332277A1 (de)
DE (1) DE69937996T2 (de)
ES (1) ES2299245T3 (de)
HU (1) HUP0102154A3 (de)
IL (1) IL139385A (de)
NO (1) NO20005751L (de)
RU (1) RU2205186C2 (de)
WO (1) WO1999060018A1 (de)
ZA (1) ZA200006313B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002054088A2 (en) 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
GB0224799D0 (en) * 2002-10-25 2002-12-04 Amersham Plc Improved complex compositions
WO2004106939A2 (en) * 2003-06-03 2004-12-09 Paul Scherrer Institut Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
RU2428415C2 (ru) 2005-11-29 2011-09-10 Нихон Меди-Физикс Ко., Лтд. Соединение-предшественник органического соединения, меченного радиоактивным галогеном
WO2008060368A2 (en) * 2006-10-02 2008-05-22 Duke University Transglutaminase-binding peptides and methods of use
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
US10610608B2 (en) 2013-08-01 2020-04-07 Rochester Institute Of Technology Modular imaging agents containing amino acids and peptides
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
JP7075937B2 (ja) * 2016-11-09 2022-05-26 キアゲン サイエンシーズ， エルエルシー Ｓｅｑｕｅｎｃｉｎｇ－Ｂｙ－Ｓｙｎｔｈｅｓｉｓ法におけるイメージング試薬としての光防護性混合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041023A (en) * 1976-04-14 1977-08-09 Hoffmann-La Roche Inc. Labelled peptides
JPS59186947A (ja) * 1983-03-09 1984-10-23 Kowa Co 新規ペプチド
AU2258788A (en) * 1987-07-07 1989-01-30 Cytrx Biopool Ltd. Fibrin-binding compound and method
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
CA2127284C (en) * 1992-01-03 2002-02-05 Buck A. Rhodes Protein- and peptide-metal ion pharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
DE69830057T2 (de) * 1997-01-21 2006-06-29 Ge Healthcare Ltd., Little Chalfont MARKIERTE FAKTOR XIIIa SUBSTRATE

Also Published As

Publication number Publication date
KR100660509B1 (ko) 2006-12-22
CN1309661A (zh) 2001-08-22
KR20010043608A (ko) 2001-05-25
NO20005751L (no) 2001-01-08
US7049289B1 (en) 2006-05-23
HUP0102154A3 (en) 2009-01-28
DE69937996D1 (de) 2008-03-06
ZA200006313B (en) 2002-07-17
JP4199420B2 (ja) 2008-12-17
DE69937996T2 (de) 2009-01-02
AU3942899A (en) 1999-12-06
EP1077998B1 (de) 2008-01-16
CN101407543A (zh) 2009-04-15
WO1999060018A1 (en) 1999-11-25
IL139385A0 (en) 2001-11-25
AU762736B2 (en) 2003-07-03
BR9910468A (pt) 2001-01-09
CA2332277A1 (en) 1999-11-25
JP2006137751A (ja) 2006-06-01
HUP0102154A2 (hu) 2001-09-28
EP1077998A1 (de) 2001-02-28
NO20005751D0 (no) 2000-11-14
ATE384075T1 (de) 2008-02-15
ES2299245T3 (es) 2008-05-16
US20060292075A1 (en) 2006-12-28
RU2205186C2 (ru) 2003-05-27
JP2002515510A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
IL139385A (en) Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
AU2852595A (en) Method for preparing intermediate compounds useful in the preparation of dual action inhibitors
CA2371818A1 (en) Salicylamide-lanthanide complexes for use as luminescent markers
DE69637957D1 (de) Zusammensetzung für düngemitteladditivconzentrat
IL140437A0 (en) Pharmaceutical compositions comprising 2-quinolines
GEP20074185B (en) Incclusion complexs of aryl- heterocyclic salts
ATE80571T1 (de) Pulvermischungen auf eisenbasis.
BG101851A (en) Hepatitis vaccine
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
BG103995A (en) Reverse hydroxamate inhibitors of matrix metalloprreverse hydroxamate inhibitors of matrix metallprooteinases teinases
ZA986532B (en) Benefit agent compositions comprising mixtures of alpha-hydroxy esters.
NZ334854A (en) Foliar fertilisers including trace element compounds
IL148971A0 (en) Carbon monoxide source for preparation of transition-metal-carbonyl-complexer
EP0521871A4 (en) Alternative enzyme substrates as deodorants
AU2648495A (en) Corrosion inhibitor composition for steel
TW349000B (en) Fungicidal two-component composition based on R-metalaxyl and usage thereof
CA2186669A1 (en) Pest-controlling composition
CZ15599A3 (cs) Barevná kompozice obsahující činidlo tvořené pyrogallolovými entitami, železnatou solí a organickou kyselinou
GB2324091A (en) Metalloproteinase inhibitors
ZA9710797B (en) High coating weight iron phosphating, compositions therefor, and use of the coating formed as a lubricant carrier.
PT1211250E (pt) Derivados de taxano em c10 e composicoes farmaceuticas
WO1998031399A3 (en) Labelled factor xiiia substrates
IL151854A0 (en) Biotin-peg-substrate for a lipase assay

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees